Efficacy of Vedolizumab for Inflammatory Bowel Disease in the Setting of DiGeorge Syndrome

被引：2
|
作者：
Thau, Eve [1 ]
Moore, Hillary Aaron [1 ]
Stein, Philip [1 ]
Chen, Kathy [1 ]
机构：
[1] Drexel Univ, St Christophers Hosp Children, Coll Med, Dept Pediat,Sect Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA
来源：
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION | 2019年 / 68卷 / 05期
关键词：
MAINTENANCE THERAPY; INDUCTION;
D O I：
10.1097/MPG.0000000000002322
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E88 / E88
页数：1
相关论文
共 50 条
  • [41] Ustekinumab and vedolizumab for extraintestinal manifestations in inflammatory bowel disease
    Livne-Margolin, M.
    Ling, D.
    Konyo, S. Attia
    Haj, O.
    Abitbol, C. M.
    Ben-Horin, S.
    Kopylov, U.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I429 - I430
  • [42] EFFECT OF OBESITY ON VEDOLIZUMAB RESPONSE IN INFLAMMATORY BOWEL DISEASE
    Levine, Louis
    Gaidos, Jill K.
    Proctor, Deborah D.
    Viana, Artur V.
    Al Bawardy, Badr
    GASTROENTEROLOGY, 2021, 160 (06) : S703 - S704
  • [43] Metabolomic predictors of response to vedolizumab in Inflammatory Bowel Disease
    Reider, S.
    Watschinger, C.
    Koch, R.
    Tilg, H.
    Moschen, A.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I522 - I522
  • [44] EFFECTS OF VEDOLIZUMAB ON EXTRAINTESTINAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE
    Dimopoulos, Christina
    Hung, Kenneth W.
    Proctor, Deborah D.
    Ruggiero, Elizabeth
    Al-Bawardy, Badr
    GASTROENTEROLOGY, 2020, 158 (06) : S675 - S675
  • [45] Vedolizumab Use in Pediatric Patients With Inflammatory Bowel Disease
    Singh, Namita
    Patel, Minesh
    Rabizadeh, Shervin
    Dubinsky, Marla
    GASTROENTEROLOGY, 2015, 148 (04) : S72 - S72
  • [46] Vedolizumab-induced acne in inflammatory bowel disease
    Gilhooley, Eimear
    Doherty, Glen
    Lally, Aoife
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2018, 57 (06) : 752 - 753
  • [47] Ustekinumab and vedolizumab for extraintestinal manifestations in inflammatory bowel disease
    Livne-Margolin, M.
    Ling, D.
    Konyo, S. Attia
    Haj, O.
    Abitbol, C. M.
    Ben-Horin, S.
    Kopylov, U.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I429 - I430
  • [48] Therapeutic drug monitoring of vedolizumab in inflammatory bowel disease
    Torres, N.
    Martin Arranz, D.
    Sanchez Azofra, M.
    Martin Arranz, E.
    Garcia, L.
    Nozal, P.
    Pascual, J.
    Apraiz, I.
    Lopez, M.
    Arteta, D.
    Nagore, D.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S387 - S387
  • [49] ANTI-TNF EFFICACY AFTER PRIMARY VEDOLIZUMAB FAILURE IN PEDIATRIC INFLAMMATORY BOWEL DISEASE
    Dolinger, Michael
    Rolfes, Priya
    Phan, Becky
    Pan, Stephanie
    Dubinsky, Marla
    INFLAMMATORY BOWEL DISEASES, 2020, 26 : S71 - S72
  • [50] REAL-WORLD SAFETY AND EFFICACY OF USTEKINUMAB AND VEDOLIZUMAB IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Hsu, Diane
    Lee, Justin
    Kotzen, Alison Borrman
    Bensen, Rachel
    Goyal, Alka
    GASTROENTEROLOGY, 2024, 166 (05) : S1210 - S1211
12345